| JVSNX | VMVAX | JVSNX / VMVAX | |
| Total Expense Ratio | 0.91 | 0.07 | 1,300% |
| Annual Report Gross Expense Ratio | 1.16 | 0.07 | 1,657% |
| Fund Existence | 9 years | 15 years | - |
| Gain YTD | 10.881 | 15.554 | 70% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 71.7M | 37.2B | 0% |
| Annual Yield % from dividends | 0.46 | 1.88 | 25% |
| Returns for 1 year | 5.48 | 20.99 | 26% |
| Returns for 3 years | 21.52 | 43.21 | 50% |
| Returns for 5 years | 24.94 | 48.08 | 52% |
| Returns for 10 years | N/A | 124.62 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NQCAX | 6.58 | 0.04 | +0.61% |
| Nuveen Large Cap Value Opportunities A | |||
| BRUEX | 18.82 | 0.11 | +0.59% |
| MFS Blended Research Value Equity B | |||
| GSSCX | 10.98 | 0.05 | +0.46% |
| Goldman Sachs Small Cap Value C | |||
| MRSRX | 27.46 | 0.08 | +0.29% |
| MFS Research International R2 | |||
| SSMHX | 375.76 | -1.00 | -0.27% |
| State Street Small/Mid Cap Equity Index | |||